From the Publisher: Biosimilars, Biogenerics, or Follow-On Biologics to Licensed Materials
BioProcessing Journal · 27.07.2026 · 6
DOI: 10.12665/j72.kcarson ↗Kurz gefasst
Fachartikel in der Zeitschrift BioProcessing Journal, online erschienen am 27.07.2026. Verfasst von Keith L. Carson.
Abstract (Originalsprache)
There are many examples of efforts to make biosimilar products, such as every time a product is taken to a larger scale, and when an established product is transferred to another facility, including a contract manufacturing site. While most of these examples have resulted in products which were indistinguishable for all practical purposes, others revealed troubling differences during product characterization or clinical administration...
Zitieren
APA
Carson, K. L. (2026). From the Publisher: Biosimilars, Biogenerics, or Follow-On Biologics to Licensed Materials. BioProcessing Journal, 6. https://doi.org/10.12665/j72.kcarson
Vancouver
Carson KL. From the Publisher: Biosimilars, Biogenerics, or Follow-On Biologics to Licensed Materials. BioProcessing Journal. 2026:6. doi:10.12665/j72.kcarson
BibTeX
@article{Carson2026,
author = {Carson, Keith L.},
title = {From the Publisher: Biosimilars, Biogenerics, or Follow-On Biologics to Licensed Materials},
journal = {BioProcessing Journal},
year = {2026},
pages = {6},
doi = {10.12665/j72.kcarson}
}
EUVIMED